Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Pirfenidone Newbury Gets Approved By Norwegian Health Authorities

May 12 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * PIRFENIDONE NEWBURY APPROVED BY THE NORWEGIAN HEALTH
AUTHORITIES
    * MARKETING AUTHORIZATION (MA) OF PIRFENIDONE NEWBURY 267 &
801 MG
FILM-COATED TABLETS IN NORWAY AS FIRST COUNTRY IN A SCANDINAVIAN
REGISTRATION PROCEDURE
    * APPROVALS IN SWEDEN AND DENMARK ARE EXPECTED TO FOLLOW
UPON
FINALIZED NATIONAL REVIEWS

Source text for Eikon:  ID:nMFN9kcv1j 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on Newbury Pharmaceuticals AB

See all news